Biotech Archives - Boston Life Sciences Times

Alnylam to Invest $250 Million to Expand U.S. Manufacturing With Enzymatic Ligation Platform

December 17, 2025

Revvity Introduces Signals Xynthetica AI Platform for Molecular and Materials Discovery

December 16, 2025

Capital Discipline Matters: Sam Zell’s Lessons for Every Entrepreneur

December 13, 2025

THIS WEEK'S STORIES

Syremis Therapeutics Launches With $165 Million Series A to Advance New Treatments for Mental Health Disorders

December 19, 2025

ImmunityBio Wins EMA Recommendation for Conditional Approval of ANKTIVA With BCG for Bladder Cancer

December 12, 2025

DexCare Appoints Rakshay Jain as Chief Product Officer to Advance Patient Navigation Platform

December 15, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Biotech

Nimbus Therapeutics Completes Dose Escalation in Phase 1/2 Trial of WRN Inhibitor for MSI-H Tumors

Alnylam to Invest $250 Million to Expand U.S. Manufacturing With Enzymatic Ligation Platform

Valink Therapeutics, Nona Biosciences Form Strategic Biologics Discovery Alliance

nChroma Bio Receives Clinical Trial Authorization to Launch First-in-Human Study of CRMA-1001 for Chronic Hepatitis B

Fondazione Telethon, Orphan Therapeutics Accelerator outline non-profit pathway for U.S. access to ultra-rare gene therapy

Most Read

Manifold Raises $18 Million Series B to Expand Vertical AI Platform for Life Sciences

PureTech Appoints Robert Lyne as Chief Executive Officer

Orum Therapeutics Raises Approximately $100 Million to Advance Degrader Antibody Conjugate Programs

Syremis Therapeutics Launches With $165 Million Series A to Advance New Treatments for Mental Health Disorders

EDITOR PICKS

Alnylam to Invest $250 Million to Expand U.S. Manufacturing With Enzymatic Ligation Platform

Revvity Introduces Signals Xynthetica AI Platform for Molecular and Materials Discovery

Capital Discipline Matters: Sam Zell’s Lessons for Every Entrepreneur

THIS WEEK'S STORIES

Syremis Therapeutics Launches With $165 Million Series A to Advance New Treatments for Mental Health Disorders

ImmunityBio Wins EMA Recommendation for Conditional Approval of ANKTIVA With BCG for Bladder Cancer

DexCare Appoints Rakshay Jain as Chief Product Officer to Advance Patient Navigation Platform

POPULAR CATEGORY

ABOUT US

FOLLOW US